Brexafemme (Ibrexafungerp)
- Medicine Name: Brexafemme
- Generic Name: Ibrexafungerp
- Dosage Form & Strength: Tablets: 150 mg
- Manufactured By: Scynexis, Inc.
Medical Uses
Brexafemme comes as an oral tablet that contains ibrexafungerp citrate, a triterpenoid antifungal agent. It is widely used in adults and post-menarchal pediatric females for:
- Treatment of vulvovaginal candidiasis (VVC) or Vaginal Yeast Infection.
- Reduction in the occurrence of recurrent vulvovaginal candidiasis (RVVC).
Recommended Dosage: Brexafemme tablets may be taken with or without food, exactly as your doctor tells you to take them. Take two tablets (300 mg) orally in the morning, and take two tablets (300) orally in the evening. If possible, the two doses (2 pills each) should be taken approximately 12 hours apart.
Treatment of VVC: The recommended dosage in adult and post-menarchal pediatric females is 300 mg (2 Brexafemme 150 mg tablets) administered around 12 hours apart (in the morning and in the evening) for one day, for a total daily dosage of 600 mg (4 Brexafemme 150 mg tablets).
Reduction in the Incidence of RVVC: The recommended dosage in adult and post-menarchal pediatric females is 300 mg (2 Brexafemme 150 mg tablets) administered around 12 hours apart (in the morning and in the evening) for a single day, for a total daily dosage of 600mg (four 150 mg pills of Brexafemme) monthly for 6 months.
Warning & Precautions
- Brexafemme 150 mg is contraindicated in pregnancy because it may be responsible for causing fetal harm behalf of the data from animal reproductive studies.
- For females of reproductive age, verify that the respective patient is not pregnant before starting Ibrexafungerp 150 mg treatment. Reassessing the pregnancy status before each dose is recommended when this medicine is used monthly for six months for a reduction in the incidence of RVVC.
- Females of reproductive age should use appropriate contraception during the treatment of VVC (vulvovaginal candidiasis) and throughout the six-month treatment time span for a reduction in the incidence of RVVC with Brexafemme tablets and, for four days after the final dose.
- Patients should inform their healthcare specialist if they are on any other medicines as certain medicines can boost or scale down blood concentrations of Ibrexafungerp or Ibrexafungerp may boost or scale down blood concentrations of certain medicines.
Documentation & Availability
What documents are required to import BREXAFEMME to India?
BREXAFEMME (ibrexafungerp) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is BREXAFEMME available in India?
BREXAFEMME (ibrexafungerp tablet) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
BREXAFEMME can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of BREXAFEMME (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Brexafemme price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the BREXAFEMME (Cancer Treatment Medicines) from across the globe and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Brexafemme®?
Ibrexafungerp is a Generic Name for the trade name drug Brexafemme®.
What is the Manufacturer’s Name of Brexafemme®?
Brexafemme® is manufactured by Scynexis, Inc.
Is Brexafemme® approved by the FDA?
Yes, Brexafemme® is approved by the FDA. Date of first approval: June 1, 2021.
What is the dosage and form of Brexafemme® supplied?
Brexafemme® is supplied as Tablets: 150 mg for oral administration.
What are the most common side effects of Brexafemme®?
The most common side effects of Brexafemme® include nausea, loose stools, vomiting, dizziness, and stomach pain.
How much does Brexafemme® cost in India?
The medicine Brexafemme cost in India can vary. To buy this triterpenoid antifungal agent authentically, one can Call/WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Brexafemme® Tablets?
Tablets of Brexafemme are packaged in polyvinyl/polyvinylidene chloride child-proof blister packs, four tablets per pack. Store at 20-25°C (68-77°F). Brief exposure to 15-30°C (59-86°F) is permitted.
Is it safe to buy Brexafemme® tablets online from India?
Yes, you can buy Brexafemme tablets online at the best price from the S S Healthcare if the medicine has not been approved or is not available in your home country.
What are the Highlights of prescribing information for Brexafemme®?
Click Here to download full Brexafemme prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
